Shanghai Shyndec Pharmaceutical Co Ltd (600420)

Currency in CNY
9.83
-0.57(-5.48%)
Closed·
Unusual trading volume
Trading near 52-week Low
600420 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9.689.94
52 wk Range
9.6811.80
Key Statistics
Bid/Ask
9.84 / 9.85
Prev. Close
10.4
Open
9.8
Day's Range
9.68-9.94
52 wk Range
9.68-11.8
Volume
31.62M
Average Volume (3m)
11.59M
1-Year Change
-2.6733%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600420 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and develops, produce, and sell of pharmaceutical products in China. The company offers nifedipine controlled release tablets, penicillin industrial potassium salt, touboke yuekui granules/capsules, sodium cefuroxime for injection, D-7ACA, fermented products, milnacipran hydrochloride tablets, compound licorice tablets, and cefoperazone dispersible tablets; and cefuroxime axetil tablets, cefuroxime sodium for injection, cefaclor extended-release capsules, cefixime granules, and cefdinir dispersible tablets. It also offers nifedipine controlled-release tablets, amlodipine besylate tablets, enalapril maleate tablet, pravastatin sodium tablets, olmesartan medoxomil hydrochlorothiazide tablets, olmesartan amlodipine tablets; milnaprom hydrochloride tablets, lofen codeine tablets, gastrodin injection, naloxone hydrochloride injection, piracetam injection; and apmis film, tacrolimus capsules, mannan peptide for injection, imatinib mesylate. In addition, the company provides methylprednisolone sodium succinate for injection, octreotide acetate injection, betamethasone sodium phosphate for injection, dexamethasone sodium phosphate injection; diclofenac sodium sustained release tablets; 6-aminopenicillinic acid, azithromycin, amoxicillin, potassium clavulanate microcrystalline cellulose, ceftriaxone sodium crude salt, 7-aminocephalosporanic acid, chorionic gonadotropin, urinary gonadotropin; and naphazoline hydrochloride nasal drops, Ambroxol Hydrochloride Oral Solution. Shanghai Shyndec Pharmaceutical Co., Ltd. was founded in 1996 and is based in Shanghai, China.

Employees
11472
Market
China

Compare 600420 to Peers and Sector

Metrics to compare
600420
Peers
Sector
Relationship
P/E Ratio
14.0x18.6x−0.4x
PEG Ratio
−1.070.890.00
Price/Book
1.0x2.4x2.6x
Price / LTM Sales
1.4x3.1x3.2x
Upside (Analyst Target)
-35.0%51.5%
Fair Value Upside
Unlock18.7%6.8%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.70%
Dividend Yield
2.88%
Industry Median 1.50%
Annualized payout
0.30
Paid annually
5-Years Growth
+24.57%
Growth Streak

Earnings

Latest Release
Mar 30, 2026
EPS / Forecast
0.11 / --
Revenue / Forecast
2.44B / --
EPS Revisions
Last 90 days

600420 Income Statement

FAQ

What Is the Shanghai Shyndec Pharm (600420) Stock Price Today?

The Shanghai Shyndec Pharm stock price today is 9.83 CNY.

What Stock Exchange Does Shanghai Shyndec Pharm Trade On?

Shanghai Shyndec Pharm is listed and trades on the Shanghai Stock Exchange.

What Is the Stock Symbol for Shanghai Shyndec Pharm?

The stock symbol for Shanghai Shyndec Pharm is "600420."

Does Shanghai Shyndec Pharm Pay Dividends? What’s The Current Dividend Yield?

The Shanghai Shyndec Pharm dividend yield is 2.9%.

What Is the Shanghai Shyndec Pharm Market Cap?

As of today, Shanghai Shyndec Pharm market cap is 13.21B CNY.

What Is Shanghai Shyndec Pharm's Earnings Per Share (TTM)?

The Shanghai Shyndec Pharm EPS (TTM) is 0.70.

When Is the Next Shanghai Shyndec Pharm Earnings Date?

Shanghai Shyndec Pharm will release its next earnings report on Apr 30, 2026.

From a Technical Analysis Perspective, Is 600420 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Shanghai Shyndec Pharm Stock Split?

Shanghai Shyndec Pharm has split 5 times.

How Many Employees Does Shanghai Shyndec Pharm Have?

Shanghai Shyndec Pharm has 11472 employees.

What is the current trading status of Shanghai Shyndec Pharm (600420)?

As of Apr 13, 2026, Shanghai Shyndec Pharm (600420) is trading at a price of 9.83 CNY, with a previous close of 10.40 CNY. The stock has fluctuated within a day range of 9.68 CNY to 9.94 CNY, while its 52-week range spans from 9.68 CNY to 11.80 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.